MedTrace Logo

Prophylactic Tranexamic Acid Use After Vaginal Delivery

NCT05429580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2023-12-04

No results posted yet for this study

Summary

In this study, our aim was to evaluate the effectiveness of prophylactic tranexamic acid use after vaginal delivery in pregnant women aged 18-45 years and 34-42 weeks according to the risk of postpartum hemorrhage.

Conditions

  • Postpartum Hemorrhage
  • Vaginal Delivery
  • Prophylactic Tranexamic Acid Use

Interventions

DRUG

Tranexamic acid

given intravenous tranexamic acid

OTHER

5% Dextrose

given placebo.

Sponsors & Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

    collaborator OTHER

  • Sanliurfa Mehmet Akif Inan Education and Research Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05429580 on ClinicalTrials.gov